Theoretical basis of a beneficial role for vitamin D in viral hepatitis

World J Gastroenterol. 2012 Oct 14;18(38):5338-50. doi: 10.3748/wjg.v18.i38.5338.

Abstract

Abnormal bone metabolism and dysfunction of the calcium-parathyroid hormone-vitamin D axis have been reported in patients with viral hepatitis. Some studies suggested a relationship between vitamin D and viral hepatitis. Genetic studies have provided an opportunity to identify the proteins that link vitamin D to the pathology of viral hepatitis (i.e., the major histocompatibility complex class II molecules, the vitamin D receptor, cytochrome P₄₅₀, the renin-angiotensin system, apolipoprotein E, liver X receptor, toll-like receptor, and the proteins regulated by the Sp1 promoter gene). Vitamin D also exerts its effects on viral hepatitis via non-genomic factors, i.e., matrix metalloproteinase, endothelial vascular growth factor, prostaglandins, cyclooxygenase-2, and oxidative stress. In conclusion, vitamin D could have a beneficial role in viral hepatitis. Calcitriol is best used for viral hepatitis because it is the active form of the vitamin D₃ metabolite.

Keywords: Calcitriol; Hepatitis; Hepatitis B virus; Hepatitis C virus; Vitamin D.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism
  • Calcitriol / therapeutic use*
  • Hepatitis B / complications
  • Hepatitis B / drug therapy
  • Hepatitis B / genetics
  • Hepatitis B / metabolism*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy
  • Hepatitis C / genetics
  • Hepatitis C / metabolism*
  • Humans
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood
  • Vitamin D / metabolism*
  • Vitamin D / therapeutic use
  • Vitamin D Deficiency / drug therapy
  • Vitamin D Deficiency / metabolism
  • Vitamin D Deficiency / virology*
  • Vitamins / therapeutic use*

Substances

  • Biomarkers
  • Vitamins
  • Vitamin D
  • 25-hydroxyvitamin D
  • Calcitriol